414 related articles for article (PubMed ID: 21312349)
1. Estimation of minimum clinically important difference for pain in fibromyalgia.
Mease PJ; Spaeth M; Clauw DJ; Arnold LM; Bradley LA; Russell IJ; Kajdasz DK; Walker DJ; Chappell AS
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):821-6. PubMed ID: 21312349
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
6. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
Farrar JT; Pritchett YL; Robinson M; Prakash A; Chappell A
J Pain; 2010 Feb; 11(2):109-18. PubMed ID: 19665938
[TBL] [Abstract][Full Text] [Related]
7. Pain response profile of patients with fibromyalgia treated with duloxetine.
Bradley LA; Wohlreich MM; Wang F; Gaynor PJ; Robinson MJ; D'Souza DN; Mease PJ
Clin J Pain; 2010; 26(6):498-504. PubMed ID: 20551724
[TBL] [Abstract][Full Text] [Related]
8. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Arnold LM; Goldenberg DL; Stanford SB; Lalonde JK; Sandhu HS; Keck PE; Welge JA; Bishop F; Stanford KE; Hess EV; Hudson JI
Arthritis Rheum; 2007 Apr; 56(4):1336-44. PubMed ID: 17393438
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
[TBL] [Abstract][Full Text] [Related]
10. Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia.
Wang F; Ruberg SJ; Gaynor PJ; Heinloth AN; Arnold LM
J Pain; 2011 Oct; 12(10):1088-94. PubMed ID: 21763211
[TBL] [Abstract][Full Text] [Related]
11. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
Chappell AS; Littlejohn G; Kajdasz DK; Scheinberg M; D'Souza DN; Moldofsky H
Clin J Pain; 2009 Jun; 25(5):365-75. PubMed ID: 19454869
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
16. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
[TBL] [Abstract][Full Text] [Related]
17. Brief pain inventory--facial minimum clinically important difference.
Sandhu SK; Halpern CH; Vakhshori V; Mirsaeedi-Farahani K; Farrar JT; Lee JY
J Neurosurg; 2015 Jan; 122(1):180-90. PubMed ID: 25361481
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
[TBL] [Abstract][Full Text] [Related]
19. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Russell IJ; Perkins AT; Michalek JE;
Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
[TBL] [Abstract][Full Text] [Related]
20. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
